These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19769721)

  • 1. A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns.
    Zhang L; Chen J; Han C
    Wound Repair Regen; 2009; 17(5):685-9. PubMed ID: 19769721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of recombinant human granulocyte-macrophage colony stimulating factor on wound healing in patients with deep partial thickness burn].
    Wang ZY; Zhang Q; Liao ZJ; Han CM; Lv GZ; Luo CQ; Chen J; Yang SX; Yang XD; Liu Q
    Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):107-10. PubMed ID: 18785409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds.
    Yan H; Chen J; Peng X
    Burns; 2012 Sep; 38(6):877-81. PubMed ID: 22652468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase Ⅳ clinical trial for external use of recombinant human granulocyte-macrophage colony-stimulating factor gel in treating deep partial-thickness burn wounds].
    Liu J; Liao ZJ; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):542-8. PubMed ID: 27647071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site.
    Ma B; Cheng DS; Xia ZF; Ben DF; Lu W; Cao ZF; Wang Q; He J; Chai JK; Shen CA; Sun YH; Zhang GA; Hu XH
    Wound Repair Regen; 2007; 15(6):795-9. PubMed ID: 18028126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the use of recombinant human granulocyte-macrophage colony-stimulating factor hydrogel externally to treat residual wounds of extensive deep partial-thickness burn.
    Yuan L; Minghua C; Feifei D; Runxiu W; Ziqiang L; Chengyue M; Wenbo J
    Burns; 2015 Aug; 41(5):1086-91. PubMed ID: 25703666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bovine basic fibroblast growth factor accelerates wound healing in patients with burns, donor sites and chronic dermal ulcers.
    Fu X; Shen Z; Chen Y; Xie J; Guo Z; Zhang M; Sheng Z
    Chin Med J (Engl); 2000 Apr; 113(4):367-71. PubMed ID: 11775238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of recombinant human granulocyte-macrophage colony-stimulating factor on wound debridement and healing of deep II thickness burn].
    Liu L; Fang Y; Yao M; Yu W; Li X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Sep; 25(9):1059-62. PubMed ID: 21991809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human granulocyte macrophage colony stimulating factor in deep second-degree burn wound healing.
    Yan D; Liu S; Zhao X; Bian H; Yao X; Xing J; Sun W; Chen X
    Medicine (Baltimore); 2017 Jun; 96(22):e6881. PubMed ID: 28562537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human recombinant growth hormone on donor-site healing in burned adults.
    Losada F; García-Luna PP; Gómez-Cía T; Garrido M; Pereira JL; Marín F; Astorga R
    World J Surg; 2002 Jan; 26(1):2-8. PubMed ID: 11898025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-degree burns: a comparative, multicenter, randomized trial of hyaluronic acid plus silver sulfadiazine vs. silver sulfadiazine alone.
    Costagliola M; Agrosì M
    Curr Med Res Opin; 2005 Aug; 21(8):1235-40. PubMed ID: 16083533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of improved topical agents on healing time of deep second-degree burn wound].
    Yang HM; Chai JK; Guo ZR
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 May; 15(3):162-4. PubMed ID: 11393958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of recombinant human granulocyte-macrophage colony-stimulating factor in healing pediatric severe burns.
    Chi YF; Chai JK; Luo HM; Zhang QX; Feng R
    Genet Mol Res; 2015 Mar; 14(1):2735-41. PubMed ID: 25867422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical observation of the long-term effects of rhEGF on deep partial-thickness burn wounds].
    Wang GY; Xia ZF; Zhu SH; Tang HT; Huan JN; Chen YL; Ge SD
    Zhonghua Shao Shang Za Zhi; 2003 Jun; 19(3):167-8. PubMed ID: 12921622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation for rhGM-CSF wound-healing efficacy in topical vehicles.
    Memişoğlu E; Oner F; Ayhan A; Başaran I; Hincal AA
    Pharm Dev Technol; 1997 May; 2(2):171-80. PubMed ID: 9552443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
    Santos JB; de Jesus AR; Machado PR; Magalhães A; Salgado K; Carvalho EM; Almeida RP
    J Infect Dis; 2004 Nov; 190(10):1793-6. PubMed ID: 15499535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A liposome hydrogel with polyvinyl-pyrrolidone iodine in the local treatment of partial-thickness burn wounds.
    Homann HH; Rosbach O; Moll W; Vogt PM; Germann G; Hopp M; Langer-Brauburger B; Reimer K; Steinau HU
    Ann Plast Surg; 2007 Oct; 59(4):423-7. PubMed ID: 17901735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of recombinant human granulocyte macrophage colony-stimulating factor for treating deep second-degree burns: a systematic review and meta-analysis.
    Li J; Liu W; Zhang G; Wang D; Lou H; Duang J
    BMJ Mil Health; 2020 Oct; 166(5):352-357. PubMed ID: 32217688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the influence on the prognosis and safety of arginine in patients with severe trauma and burns--a multi-center randomized double blinded, placebo controlled, clinical trail in 86 patients].
    Peng X; Yi D; Fan SZ; Liao ZJ; Yao YZ; Cong TQ; Xiang J; Wang ZY; Meng DS; You ZY
    Zhonghua Shao Shang Za Zhi; 2006 Aug; 22(4):243-6. PubMed ID: 17175635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human GM-CSF in the treatment of poorly healing wounds.
    Groves RW; Schmidt-Lucke JA
    Adv Skin Wound Care; 2000; 13(3 Pt 1):107-12. PubMed ID: 11075003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.